American Vietnamese Biotech Incorporation (HNX:AMV)
Vietnam · Delayed Price · Currency is VND 1,200.00
-100.00 (-7.69%)
At close: Aug 12, 2026
HNX:AMV Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 157,327 | 262,211 | 196,658 | 511,312 | 432,649 | 1,311,968 | |
Market Cap Growth | -40.00% | 33.33% | -61.54% | 18.18% | -67.02% | 63.02% |
Enterprise Value | 375,592 | 465,766 | 400,671 | 648,941 | 242,218 | 1,392,443 |
Last Close Price | 1200.00 | 2000.00 | 1500.00 | 3900.00 | 3300.00 | 13761.65 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 47.85 | 8.02 | 15.95 |
PS Ratio | 1.54 | 1.64 | 0.63 | 2.60 | 1.54 | 5.86 |
PB Ratio | 0.10 | 0.16 | 0.12 | 0.30 | 0.26 | 1.08 |
P/TBV Ratio | 0.11 | 0.19 | 0.13 | 0.33 | 0.28 | 1.18 |
P/FCF Ratio | 3.86 | 0.70 | 0.31 | - | - | - |
P/OCF Ratio | 2.76 | 0.68 | 0.29 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.67 | 2.92 | 1.29 | 3.30 | 0.86 | 6.22 |
EV/EBITDA Ratio | - | - | 20.41 | 11.95 | 2.89 | 12.05 |
EV/EBIT Ratio | - | - | - | 19.99 | 3.82 | 13.97 |
EV/FCF Ratio | 9.22 | 1.25 | 0.64 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.10 | 0.09 | 0.09 | 0.10 | 0.10 | 0.15 |
Debt / EBITDA Ratio | - | - | 7.88 | 3.07 | 2.03 | 1.58 |
Debt / FCF Ratio | 3.94 | 0.40 | 0.25 | - | - | - |
Net Debt / Equity Ratio | 0.10 | 0.06 | 0.08 | 0.05 | 0.06 | 0.13 |
Net Debt / EBITDA Ratio | -13.27 | -4.03 | 7.00 | 1.52 | 1.10 | 1.33 |
Net Debt / FCF Ratio | 3.73 | 0.23 | 0.22 | -0.57 | -0.27 | -0.30 |
Asset Turnover | 0.05 | 0.08 | 0.16 | 0.10 | 0.16 | 0.18 |
Inventory Turnover | 1.29 | 2.73 | 1.54 | 0.53 | 0.74 | 0.64 |
Quick Ratio | 1.44 | 1.65 | 2.03 | 1.57 | 1.73 | 1.01 |
Current Ratio | 2.17 | 2.31 | 6.10 | 9.93 | 8.13 | 6.40 |
Return on Equity (ROE) | -4.52% | -4.56% | -0.78% | 0.64% | 3.82% | 8.05% |
Return on Assets (ROA) | -0.96% | -1.43% | -0.14% | 1.02% | 2.25% | 5.11% |
Return on Invested Capital (ROIC) | -1.81% | -2.52% | -0.24% | 1.72% | 3.95% | 9.03% |
Return on Capital Employed (ROCE) | -1.90% | -2.80% | -0.20% | 1.80% | 3.50% | 7.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -45.23% | -27.70% | -5.69% | 2.09% | 12.46% | 6.27% |
FCF Yield | 25.90% | 142.00% | 319.61% | -28.32% | -80.36% | -38.94% |
Payout Ratio | - | - | - | 8.19% | - | - |
Buyback Yield / Dilution | -0.01% | - | - | -22.04% | -27.63% | -58.37% |
Total Shareholder Return | -0.01% | - | - | -22.04% | -27.63% | -58.37% |